Such a loss of LSEC fenestrations can hinder insulin and lipoprotein transport, leading to hepatic insulin resistance, reduced clearance of insulin, diabetes, dyslipidemia, and atherosclerosis [55]. This evidence concerns the gene INS and metabolic syndrome.